Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions

Journal of the American Geriatrics Society

Volumn 44, Issue 10, 1996, Pages 1242-1250

  Plassman, Brenda L ^a   Breitner, John C S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; GENE PRODUCT; PROTEIN PRECURSOR;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CHROMOSOME ANALYSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PATHOGENESIS; SYMPTOMATOLOGY;

EID: 0029840047     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb01377.x     Document Type: Article

References (150)

1. Sulkava R, Wikstrom J, Aromaa A et al. Prevalence of severe dementia in Finland. Neurology 1985;35:1025-1029.
2. Zhang MY, Katzman R, Salmon D et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education. Ann Neurol 1990;27:428-437.
3. Rocca WA, Bonaiuto S, Lippi A et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door-to-door survey in Appignano, Macerata Province, Italy. Neurology 1990;40:626-631.
4. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.
5. Jellinger K. Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol Belg 1976;76:83-102.
6. Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990;95:239-258.
7. Brun A, Gustafson L. The Lund Longitudinal Dementia Study: A 25-year perspective on neuropathology, differential diagnosis and treatment. In: Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P, eds. Alzheimer's Disease: Advances in Clinical and Basic Research. New York: John Wiley & Sons, 1993, pp 3-18.
8. Sjogren T. A genetic study of morbus Alzheimer and morbus Pick. Acta Psychiatry Neurol Scand 1952;82(suppl):9-63.
9. Larsson T, Sjogren T, Jacobson G. Senile dementia. A clinical, sociomedical and genetic study. Acta Psychiatr Scand 1963;39(suppl 167): 1-259.
10. Heston LL, Mastri AR, Anderson VE, White J. Dementia of the Alzheimer type: Clinical genetics, natural history and associated conditions. Arch Gen Psychiatry 1981;38:1085-1090.
11. Breitner JCS, Folstein MF. Familial Alzheimer dementia: A prevalent disorder with specific, clinical features. Psychol Med 1984;1:63-80.
12. Amaducci LA, Fratiglioni L, Rocca WA et al. Risk factors for clinically diagnosed Alzheimer's disease: A case control study of an Italian population. Neurology 1986;36:922-931.
13. Fitch N, Becker R, Heller A. The inheritance of Alzheimer's disease: A new interpretation. Ann Neurol 1988;23:14-19.
14. van Duijn CM, Clayton D, Chandra V et al. Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S13-20.
15. Chandra V, Philipose V, Bell PA et al. Case-control study of late onset "probable Alzheimer's disease". Neurology 1987;37:1295-1300.
16. Kennedy AM, Brown J, Rossor M. The genetics of Alzheimer's disease. Baillieres Clin Neurol 1994;3:217-240.
17. Bird TD. Clinical genetics of familial Alzheimer disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York: Raven Press, 1994, pp 65-74.
18. Plomin R, DeFries JC, McClearn GE. Twin Studies. Behavioral Genetics - A Primer, 2nd Ed. New York: W.H. Freeman, 1990, pp 309-340.
19. Kumar A, Schapiro MB, Grady CL et al. Anatomic, metabolic, neuropsychological, and molecular genetic studies of three pairs of identical twins discordant for dementia of the Alzheimer's type. Arch Neurol 1991;48:160-168.
20. Creasey H, Jorm A, Longley W et al. Monozygotic twins discordant for Alzheimer's disease. Neurology 1989;39:1474-1476.
21. Renvoize EB, Mindham RHS, Stewart M et al. Identical twins discordant for presenile dementia of the Alzheimer type. Br J Psychiatry 1986;149:509-512.
22. Karlinsky H, Berg JM, Lennox A et al. Monozygotic twins concordant for late-onset probable Alzheimer disease with suspected Alzheimer disease in four sibs, Am J Med Genet 1992;44:591-597.
23. Nee LE, Polinsky RJ, Eldridge R et al. A family with histologically confirmed Alzheimer's disease. Arch Neurol 1983;40:203-208.
24. Bergem ALM. Heredity in dementia of the Alzheimer type. Clin Genet 1994;46:144-149.
25. Breitner JCS, Welsh KA, Gau BA et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-771.
26. Breitner JCS, Murphy EA, Folstein MF. Familial aggregation in Alzheimer dementia II: Clinical genetic implications of age-dependent onset. J Psychiatr Res 1986;20:45-55.
27. Schellenberg GD. Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci USA 1995;92:8552-8559.
28. Van Broeckhoven CL. Molecular genetics of Alzheimer disease: Identification of genes and gene mutations. Eur Neurol 1995;35:8-19.
29. Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
30. Oliver C, Holland AJ. Down's syndrome and Alzheimer's disease: A review. Psychol Med 1986;16:307-322.
31. Levy E, Carman MD, Fernandez-Madrid IJ et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-1126.
32. Suzuki N, Cheung TT, Cai XD et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 1994;264:1336-1340.
33. Burdick D, Soreghan B, Kwon M et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 1992;267:546-554.
34. Schellenberg GD, Bird TD, Wijsman EM et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-671.
35. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutation in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
36. Selkoe DJ. Missense on the membrane. Nature 1995;375:734-735.
37. Wasco W, Pettingell WP, Jondro PD et al. Familial Alzheimer's chromosome 14 mutations. Nature Med 1995;1:848.
38. Van Broeckhoven C. Presenilins and Alzheimer disease. Nature Genet 1995;11:230-232.
39. Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977.
40. Levy-Lahad E, Wijsman EM, Nemens E et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-973.
41. Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-776.
42. Querfurth HW, Wijsman EM, St George-Hyslop PH, Selkoe DJ. Beta APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Acta Neurol Belg 1995;28:319-337.
43. Pericak-Vance MA, Bebout JL, Gaskell PC et al. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.
44. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: highavidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
45. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 1993;261:921-923.
46. Schmechel DE, Saunders AM, Strittmatter WJ et al. Increased amyloid B-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
47. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993;11:575-580.
48. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
49. Brousseau T, Legrain S, Berr C et al. Confirmation of the E4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994;44:342-344.
50. Mayeux R, Stern Y, Ottman R et al. The apolipoprotein E4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
51. Kuusisto J, Koivisto K, Kervinen K et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. Br Med J 1994;309:636-638.
52. Lehtovirta M, Helisalmi S, Mannermaa A et al. Apolipoprotein E polymorphism and Alzheimer's disease in Eastern Finland. Neurosci Lett 1995;185:13-15.
53. van Duijn CM, de Knijff P, Cruts M et al. Apolipoprotein e4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-78.
54. Okuizumi K, Onodera O, Tanaka H et al. ApoE-e4 and early onset Alzheimer's. Nature Genet 1994;7:10-11.
55. Tsai MS, Tangalos EG, Petersen RC et al. Apolipoprotein E: Risk factor for Alzheimer disease. Am J Hum Genet 1994;54:643-649.
56. Lucorte G, David F, Visvikis S et al. Apolipoprotein E-e4 allele and Alzheimer's disease. Lancet 1993;342:1309.
57. Liddell M, Williams J, Bayer A et al. Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet 1994;31:197-200.
58. Lucotte G, Visvikis B, Leininger-Muler B et al. Association of apolipoprotein E allele ∈4 with late-onset sporadic Alzheimer's disease. Am J Med Genet 1994;54:286-288.
59. Mahieux F, Couderc R, Moulignier A et al. Apolipoprotein E4: Phenotype in patients with Alzheimer's disease. Ann Neurol 1994;35:506.
60. Nalbantoglu J, Gilfix BM, Bertrand P et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36:889-895.
61. Maestre G, Ottman R, Stern Y et al. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259.
62. Corder EH, Saunders AM, Risch NJ et al. Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease. Nature Genet 1994;7:180-184.
63. Tsuang D, Kukull W, Sheppard L et al. Impact of sample selection of APOE ∈4 allele frequency: A comparison of two Alzheimer's disease samples. J Am Geriatr Soc 1996;44:704-707.
64. West HL, Rebeck W, Hyman BT. Frequency of the apolipoprotein E ∈2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994;175:46-48.
65. Talbot C, Lendon C, Craddock N et al. Protection against Alzheimer's disease with apoE e2. Lancet 1994;343:1432-1433.
66. Chartier-Harlin MC, Parfitt M, Legrain S et al. Apolipoprotein E, e4 as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-574.
67. Locke PA, Conneally PM, Tanzi RE et al. Apolipoprotein E4 allele and Alzheimer disease: Examination of allelic association and effect on age at onset in both early- and late-onset cases. Genet Epidemiol 1995;12:83-92.
68. Smith AD, Johnston C, Sim E et al. Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing. Lancet 1994;34:473-474.
69. van Duijn CM, de Knijff P, Wehnert A et al. The apolipoprotein E E2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610.
70. Harrington CR, Louwagie J, Rossau R et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994;145:1472-1484.
71. Galasko D, Saitoh T, Xia Y et al. The apolipoprotein E allele E4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1951.
72. Benjamin R, Leake A, Edwardson JA et al. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 1994;343:1565.
73. Strittmatter WJ, Weisgraber KH, Huang DY et al. Binding of human apolipoprotein E to synthetic amyloid B peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102.
74. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171.
75. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-530.
76. Masliah E, Mallory M, Alford M, Mucke L. Abnormal synaptic regeneration in hAPP transgenic and APOE-knockout mice. Neurobiol Aging 1994;15:S11.
77. Gerdes LU, Klausen IC, Sihm I, Gaergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-167.
78. Hallman DM, Boerwinkle E, Saha N et al. The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349.
79. Hendrie HC, Hall KS, Hui S et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-120.
80. Sobel E, Louhija J, Sulkava R. Lack of association of apolipoprotein E allele epsilon-4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995;45:903-907.
81. Roses AD. Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease. Neurobiol Aging 1994;15 (suppl 2):S165-167.
82. Breitner JCS, Murphy EA, Silverman JM et al. Age-dependent expression of familial risk in Alzheimer's disease. Am J Epidemiol 1988;128:536-548.
83. Breitner JCS. Clinical genetics and genetic counseling in Alzheimer's disease. Ann Intern Med 1991;115:601-606.
84. Sorbi S, Nacmias B, Forleo P et al. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 1995;38:124-127.
85. St.George-Hyslop P, Crapper-McLachlan D, Tuda T et al. Alzheimer's disease and possible gene interaction. Science 1994;263:537.
86. Van Broeckhoven C. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994;169:179-180.
87. Levy-Lahad E, Lahad A, Wijsman EM, Bird TD, Schellenberg GD. Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Ann Neurol 1995;38:678-680.
88. Schlesselman JJ. Case-Control Studies: Design, Conduct, Analysis. New York: Oxford University Press, 1982.
89. Tanzi RE, Bush AI, Wasco W. Genetic studies of Alzheimer's disease: Lessons learned and future imperatives. Neurobiol Aging 1994;15(suppl 2):S145-148.
90. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995;38:6-14.
91. Mortimer JA, van Duijn CM, Chandra V et al. Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S28-35.
92. Mayeux R, Ottman R, Tang M-X et al. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 1993;33:494-501.
93. van Duijn CM, Tanja TA, Haaxma R et al. Head trauma and the risk of Alzheimer's disease. Am J Epidemiol 1992;135:775-782.
94. Graves AB, White E, Koepsell TD et al. The association between head trauma and Alzheimer's disease. Am J Epidemiol 1990;131:491-501.
95. Mayeux R, Ottman R, Maestre G et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 1995;45:555-557.
96. Hebert LE, Scherr PA, Beckett LA et al. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 1992;135:347-355.
97. Stern Y, Mayeux R. Education, occupation, and Alzheimer's disease. JAMA 1994;272:1406.
98. McDowell I, Hill G, Lindsay J et al. The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
99. Snowdon DA, Kemper SJ, Mortimer JA et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996;275:528-532.
100. Plassman BL, Welsh KA, Helms M et al. Intelligence and education as predictors of cognitive state in late life: A 50 year follow-up. Neurology 1995;45:1446-1450.
101. Loehlin JC, Willerman L, Horn JM. Human behavior genetics. Ann Rev Psychol 1988;39:101-133.
102. Lee PN. Smoking and Alzheimer's disease: A review of the epidemiological evidence. Neuroepidemiology 1994;13:131-144.
103. Plassman BL, Helms MJ, Welsh KA et al. Smoking, Alzheimer's disease, and confounding with genes. Lancet 1995;345:387.
104. Breitner JCS. Inflammatory processes and anti-inflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol Aging (in press).
105. Breitner JCS, Gau BA, Welsh KA et al. Inverse association of antiinflammatory treatments and Alzheimer's disease: Initial results of a cotwin control study. Neurology 1994;44:227-232.
106. Breitner JCS, Welsh KA, Helms MJ et al. Delayed onset of Alzheimer's disease with non-steroidal anti-inflammatory and histamine H2-blocking drugs. Neurobiol Aging 1995;16:523-530.
107. La Rue A, O'Hara R, Matsuyama SS, Jarvik LF. Cognitive changes in young-old adults: Effect of family history of dementia. J Clin Exp Neuropsychol 1995;17:65-70.
108. Reed T, Carmelli D, Swan GE et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E E4 allele. Arch Neurol 1994;51:1189-1192.
109. Bondi MW, Salmon DP, Monsch AU et al. Episodic memory changes are associated with the APOE-epsilon-4 allele in nondemented older adults. Neurology 1995;45:2203-2206.
110. Small GW, Mazziotta JC, Collins MT et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 1995;273:942-947.
111. Petersen RC, Smith GE, Ivnik RJ et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
112. Poirier J, Delisle MC, Quirion R et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995;92:12260-12264.
113. Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
114. Erkinjuntti T, Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis 1993;3:3-23.
115. Skoog I, Nilsson L, Palmertz B et al. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-158.
116. Brust JCM. Vascular dementia is overdiagnosed. Arch Neurol 1988;45:799-801.
117. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: A primer for practicing pathologists. Arch Pathol Lab Med 1993;177:132-144.
118. Brass LM, Alberts MJ. The genetics of cerebrovascular disease. Baillieres Clin Neurol 1995;4:1-23.
119. Sourander P, Walinder J. Hereditary multi-infarct dementia. Acta Neuropathol 1977;39:247-254.
120. Bowler JV, Hachinski V. Progress in the genetics of cerebrovascular disease: Inherited subcortical arteriopathies. Stroke 1994;25:1696-1699.
121. Tournier-Lasserve E, Joutel A, Melki J et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nature Genet 1993;3:256-259.
122. Tournier-Lasserve E, Joutel A, Chabriat H et al. CADASIL: Clinical phenotypes and genetic data in 15 unrelated families. Neurology 1995;45(suppl 4):A273.
123. Haan J, Algra PR, Roos RA. Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Clinical and computed tomographic analysis of 24 cases. Arch Neurol 1990;47:649-653.
124. Rozemuller AJM, Roos RAC, Bots GTAM et al. Distribution of B/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol 1993;142:1449-1457.
125. Levy E, Lopez OC, Ghiso J et al. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 1989;169:1771-1778.
126. Schnittger S, Rao W, Abrahamson M, Hansmann I. Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiography (HC-CAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2 Genomics 1993;16:50-55.
127. Van Nostrand W, Wagner SL, Haan J et al. Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid beta-protein precursor. Ann Neurol 1992;32:215-218.
128. Olichney JM, Hansen LA, Hofstetter R et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52:702-708.
129. Greenberg SM, Rebeck GW, Vonsattel JPG et al. Apolipoprotein E ∈4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-259.
130. Alberts MJ. Genetics of cerebrovascular disease. Stroke 1990;21 (suppl. III):127-130.
131. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD. A study of twins and stroke. Stroke 1992;23:221-223.
132. Kiely DK, Wolf PA, Cupples LA. Familial aggregation of stroke: The Framingham study. Stroke 1993;24:1366-1371.
133. Graffagnino C, Gasecki AP, Doig GS, Hachinski VC. The importance of family history in cerebrovascular disease. Stroke 1994;25:1599-1604.
134. Khaw KT, Barrett CE. Family history of heart attack: A modifiable risk factor? Circulation 1986;74:239-244.
135. Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking - A study of male twins. N Engl J Med 1992;327:829-833.
136. Heller DA, de Faire U, Pedersen NL et al. Genetic and environmental influences on serum lipids in twins. N Engl J Med 1993;328:1150-1156.
137. Mortel KF, Meyer JS, Herod B, Thornby J. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular type. Dementia 1995;6:55-62.
138. Ott A, Breteler MMB, van Harskamp F et al. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study. Br Med J 1995;310:970-973.
139. Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: How education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health 1992;82:816-820.
140. Feldman JJ, Makuc DM, Kleinman JC, Cornoni-Huntley J. National trends in educational differentials in mortality. Am J Epidemiol 1989;129:919-933.
141. Satz P. Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology 1993;7:273-295.
142. Sparks DL, Hunsaker JC, Scheff SW et al.. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990;11:601-607.
143. Abe K, Tanzi RE, Kogure K. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett 1991;125:172-174.
144. Kosunen O, Talasniemi S, Lehtovirta M et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995;26:743-748.
145. Frisoni GB, Calabresi L, Geroldi C et al. Apolipoprotein E ∈4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
146. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease Lancet 1993;342:737.
147. Pedro-Botet J, Senti M, Nogues X et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556-1562.
148. Saunders AM, Roses AD. Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease Stroke 1993;24:1416.
149. Betard C, Robitaille Y, Gee M et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 1994;5:1893-1896.
150. Couderc R, Mahieux F, Bailleul S et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case control study. Stroke 1993;24:661-664.